Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants

Tomokazu Tamura, Jumpei Ito, Keiya Uriu, +82

Nature Communications

Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant

Akatsuki Saito, Tomokazu Tamura, Jiří Zahradník, +46

Cell Host & Microbe

Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant

Tomokazu Tamura, Takashi Irie, Sayaka Deguchi, +86

Nature Communications

A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable site

Taishi Onodera, Shunsuke Kita, Yu Adachi, +32

Immunity

Virological characteristics of the SARS‐CoV‐2 Omicron EG.5.1 variant

Shuhei Tsujino, Sayaka Deguchi, Tomo Nomai, +45

Microbiology and Immunology

Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants

Saya Moriyama, Yuki Anraku, Shunta Taminishi, +21

Nature Communications

EngineeringViral DiagnosticsImmunologyMolecular BiologySars-cov-2-neutralizing Antibodies +17

Structural basis for receptor-binding domain mobility of the spike in SARS-CoV-2 BA.2.86 and JN.1

Hisano Yajima, Yuki Anraku, Yu Kaku, +104

Nature Communications

Virus StructureSignal TransductionReceptor-binding Domain MobilityNatural SciencesImmunology +13

Virological characteristics of the SARS-CoV-2 Omicron EG.5.1 variant

Shuhei Tsujino, Sayaka Deguchi, Tomo Nomai, +45

Viral DiagnosticsViral Polymerase MechanismViral PathogenesisEg.5.1 VariantVirological Characteristics +14

Virological characteristics of the SARS-CoV-2 XBB.1.5 variant

Tomokazu Tamura, Takashi Irie, Sayaka Deguchi, +35

Microbial PathogensViral DiagnosticsGeneticsViral PathogenesisImmunology +14

Novel super-neutralizing antibody UT28K is capable of protecting against infection from a wide variety of SARS-CoV-2 variants

Tatsuhiko Ozawa, Hideki Tani, Yuki Anraku, +21

mAbs